Home

rapporto Disperato Coincidenza jean paul kress morphosys partecipazione esplodere Manifestazione

MorphoSys on X: "Our CEO, Jean-Paul Kress, M.D., is presenting at #JPM24 on  Wednesday, January 10, at 3:00 p.m. PST in San Francisco. Join via webcast  for an overview of our key #
MorphoSys on X: "Our CEO, Jean-Paul Kress, M.D., is presenting at #JPM24 on Wednesday, January 10, at 3:00 p.m. PST in San Francisco. Join via webcast for an overview of our key #

MorphoSys ernennt Dr. Jean-Paul Kress zum neuen Chief Executive Officer |  GoingPublic.de
MorphoSys ernennt Dr. Jean-Paul Kress zum neuen Chief Executive Officer | GoingPublic.de

Jean-Paul Kress - CEO at MorphoSys | The Org
Jean-Paul Kress - CEO at MorphoSys | The Org

Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn

Jean-Paul Kress email address & phone number | Morphosys Chairman of the  Board of Management, Chief Executive Officer contact information -  RocketReach
Jean-Paul Kress email address & phone number | Morphosys Chairman of the Board of Management, Chief Executive Officer contact information - RocketReach

Jean-Paul Kress email address & phone number | Morphosys Chairman of the  Board of Management, Chief Executive Officer contact information -  RocketReach
Jean-Paul Kress email address & phone number | Morphosys Chairman of the Board of Management, Chief Executive Officer contact information - RocketReach

MorphoSys on X: "Tomorrow our CEO – Jean-Paul Kress – will be participating  in the Stifel 2021 Virtual Healthcare Conference where he'll discuss our  pipeline and our plans to redefine how #cancer
MorphoSys on X: "Tomorrow our CEO – Jean-Paul Kress – will be participating in the Stifel 2021 Virtual Healthcare Conference where he'll discuss our pipeline and our plans to redefine how #cancer

Jean-Paul Kress, M.D. on LinkedIn: Today, I am recognizing the exceptional  accomplishments of Malte Peters…
Jean-Paul Kress, M.D. on LinkedIn: Today, I am recognizing the exceptional accomplishments of Malte Peters…

MorphoSys AG Form 6-K Current Report Filed 2023-05-04
MorphoSys AG Form 6-K Current Report Filed 2023-05-04

Jean-Paul Kress: MorphoSys announced that it has entered into a business  combination agreement to be acquired by Novartis - OncoDaily
Jean-Paul Kress: MorphoSys announced that it has entered into a business combination agreement to be acquired by Novartis - OncoDaily

Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn

BioCentury - The transition from platform to product: Jean-Paul Kress on  reshaping MorphoSys
BioCentury - The transition from platform to product: Jean-Paul Kress on reshaping MorphoSys

Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn

Kress becomes new CEO of MorphoSys - BioM
Kress becomes new CEO of MorphoSys - BioM

Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn

Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn

MorphoSys AG Form 6-K Current Report Filed 2023-05-04
MorphoSys AG Form 6-K Current Report Filed 2023-05-04

MorphoSys on X: "Congratulations to our CEO Jean-Paul Kress for being  honored by @medicine_maker in their 2021 Power List https://t.co/xj45JMpr95  https://t.co/wejmu75qPH" / X
MorphoSys on X: "Congratulations to our CEO Jean-Paul Kress for being honored by @medicine_maker in their 2021 Power List https://t.co/xj45JMpr95 https://t.co/wejmu75qPH" / X

Leadership | MorphoSys
Leadership | MorphoSys

MorphoSys fails secondary in blood cancer trial, sinking stock
MorphoSys fails secondary in blood cancer trial, sinking stock

Jean-Paul Kress, M.D. - MorphoSys | LinkedIn
Jean-Paul Kress, M.D. - MorphoSys | LinkedIn

Morphosys-CEO Jean-Paul Kress im Interview: Das tut sich bei Morphosys -  DER AKTIONÄR
Morphosys-CEO Jean-Paul Kress im Interview: Das tut sich bei Morphosys - DER AKTIONÄR

MorphoSys pivots business model; Africa's vaccine financing gap | S&P  Global Market Intelligence
MorphoSys pivots business model; Africa's vaccine financing gap | S&P Global Market Intelligence

New CEO at Morphosys - European Biotechnology
New CEO at Morphosys - European Biotechnology

Jean-Paul Kress, M.D. | Morphosys de
Jean-Paul Kress, M.D. | Morphosys de

Member Spotlight: Q&A with MorphoSys - MassBio
Member Spotlight: Q&A with MorphoSys - MassBio

Dr. Jean-Paul Kress is new CEO of MorphoSys AG - Innovations- und  Gründerzentrum Biotechnologie IZB
Dr. Jean-Paul Kress is new CEO of MorphoSys AG - Innovations- und Gründerzentrum Biotechnologie IZB